Literature DB >> 23564710

Cytochrome P450-mediated metabolism of vitamin D.

Glenville Jones1, David E Prosser, Martin Kaufmann.   

Abstract

The vitamin D signal transduction system involves a series of cytochrome P450-containing sterol hydroxylases to generate and degrade the active hormone, 1α,25-dihydroxyvitamin D3, which serves as a ligand for the vitamin D receptor-mediated transcriptional gene expression described in companion articles in this review series. This review updates our current knowledge of the specific anabolic cytochrome P450s involved in 25- and 1α-hydroxylation, as well as the catabolic cytochrome P450 involved in 24- and 23-hydroxylation steps, which are believed to initiate inactivation of the vitamin D molecule. We focus on the biochemical properties of these enzymes; key residues in their active sites derived from crystal structures and mutagenesis studies; the physiological roles of these enzymes as determined by animal knockout studies and human genetic diseases; and the regulation of these different cytochrome P450s by extracellular ions and peptide modulators. We highlight the importance of these cytochrome P450s in the pathogenesis of kidney disease, metabolic bone disease, and hyperproliferative diseases, such as psoriasis and cancer; as well as explore potential future developments in the field.

Entities:  

Keywords:  1,25-(OH)2D3; CYP24A1; CYP27A1; CYP27B1; CYP2R1; chronic kidney disease; idiopathic infantile hypercalcemia; regioselectivity; vitamin D analog; vitamin D-dependent rickets

Mesh:

Substances:

Year:  2013        PMID: 23564710      PMCID: PMC3927478          DOI: 10.1194/jlr.R031534

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  162 in total

1.  FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.

Authors:  Takashi Shimada; Hisashi Hasegawa; Yuji Yamazaki; Takanori Muto; Rieko Hino; Yasuhiro Takeuchi; Toshiro Fujita; Kazuhiko Nakahara; Seiji Fukumoto; Takeyoshi Yamashita
Journal:  J Bone Miner Res       Date:  2003-12-29       Impact factor: 6.741

2.  25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis.

Authors:  D D Bikle; S Chang; D Crumrine; H Elalieh; M-Q Man; E H Choi; O Dardenne; Z Xie; R St Arnaud; K Feingold; P M Elias
Journal:  J Invest Dermatol       Date:  2004-04       Impact factor: 8.551

3.  Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1).

Authors:  O Dardenne; J Prud'homme; S A Hacking; F H Glorieux; R St-Arnaud
Journal:  Bone       Date:  2003-04       Impact factor: 4.398

4.  Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses.

Authors:  Olivier Dardenne; Josée Prudhomme; S Adam Hacking; Francis H Glorieux; René St-Arnaud
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

5.  De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase.

Authors:  Jeffrey B Cheng; Daniel L Motola; David J Mangelsdorf; David W Russell
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

6.  Rat cytochrome P450C24 (CYP24A1) and the role of F249 in substrate binding and catalytic activity.

Authors:  Andrew Annalora; Ekaterina Bobrovnikova-Marjon; Rita Serda; Letitia Lansing; Mark L Chiu; Andrzej Pastuszyn; Srinivas Iyer; Craig B Marcus; John L Omdahl
Journal:  Arch Biochem Biophys       Date:  2004-05-15       Impact factor: 4.013

7.  CYP3A4 is a human microsomal vitamin D 25-hydroxylase.

Authors:  Ram P Gupta; Bruce W Hollis; Shailendra B Patel; Kennerly S Patrick; Norman H Bell
Journal:  J Bone Miner Res       Date:  2003-12-22       Impact factor: 6.741

8.  25-hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon.

Authors:  Giovanna Bises; Enikö Kállay; Tina Weiland; Friedrich Wrba; Etienne Wenzl; Elisabeth Bonner; Stefan Kriwanek; Peter Obrist; Heide S Cross
Journal:  J Histochem Cytochem       Date:  2004-07       Impact factor: 2.479

9.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.

Authors:  Jeffrey B Cheng; Michael A Levine; Norman H Bell; David J Mangelsdorf; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

10.  Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

Authors:  Tobias Larsson; Richard Marsell; Ernestina Schipani; Claes Ohlsson; Osten Ljunggren; Harriet S Tenenhouse; Harald Jüppner; Kenneth B Jonsson
Journal:  Endocrinology       Date:  2004-02-26       Impact factor: 4.736

View more
  135 in total

Review 1.  Vitamin D: Implications for ocular disease and therapeutic potential.

Authors:  Rose Y Reins; Alison M McDermott
Journal:  Exp Eye Res       Date:  2015-02-25       Impact factor: 3.467

Review 2.  New developments in our understanding of vitamin metabolism, action and treatment.

Authors:  Sylvia Christakos; Shanshan Li; Jessica De La Cruz; Daniel D Bikle
Journal:  Metabolism       Date:  2019-06-19       Impact factor: 8.694

Review 3.  Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression.

Authors:  Abhishek Aggarwal; David Feldman; Brian J Feldman
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-11       Impact factor: 4.292

Review 4.  Biology and Mechanisms of Action of the Vitamin D Hormone.

Authors:  J Wesley Pike; Sylvia Christakos
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

Review 5.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

6.  Comparison of vitamin D metabolites in wild and captive baboons.

Authors:  Toni E Ziegler; Amita Kapoor; Neil C Binkley; Karen S Rice; Jeffrey Rogers; Clifford J Jolly; Jane E Phillips-Conroy
Journal:  Am J Primatol       Date:  2018-12       Impact factor: 2.371

7.  Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.

Authors:  Kai Yin; Yong You; Vicki Swier; Lin Tang; Mohamed M Radwan; Amit N Pandya; Devendra K Agrawal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

Review 8.  The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.

Authors:  Yunsheng Liang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 9.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

10.  Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds.

Authors:  Naing Lin Shan; Audrey Minden; Philip Furmanski; Min Ji Bak; Li Cai; Roman Wernyj; Davit Sargsyan; David Cheng; Renyi Wu; Hsiao-Chen D Kuo; Shanyi N Li; Mingzhu Fang; Hubert Maehr; Ah-Ng Kong; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2020-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.